Skip to main content
Fig. 3 | BMC Gastroenterology

Fig. 3

From: Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization

Fig. 3

A Calibration plot of EZ-ALBI and ALBI scores for one-, two- and three-year mortality B Decision curve analysis for EZ-ALBI, ALBI, CTP, and MELD scores in terms of one-, two- and three-year mortality ALBI, albumin-bilirubin; CI, confident interval, EZ-ALBI albumin-bilirubin, MELD, model for end-stage liver disease.

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us